KRT19
HGNC:6436 MIM.148020
Prognosis marker
In a multivariate analysis, the CK19 status is shown to be independent of the WHO criteria. CK19 staining is a potential additional prognostic marker independent from the WHO criteria for pancreatic endocrine tumors. (#18059224#)
References
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Schmitt AM, Anlauf M, Rousson V, Schmid S, Kofler A, Riniker F, Bauersfeld J, Barghorn A, Probst-Hensch NM, Moch H, Heitz PU, Kloeppel G, Komminoth P, Perren A. Am J Surg Pathol. 2007 Nov;31(11):1677-82. PMID: #18059224#
Nasser SM, Pitman MB, Pilch BZ, Faquin WC. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining. Cancer. 2000 Oct 25;90(5):307-11. PMID: #11038428#